| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  SOFILARO / CALEN [Automatic translation follows] Since 1983, SOFILARO Gestion, a subsidiary of the Caisses Régionales de Crédit Agricole Languedoc and Sud Méditerranée, has played a dynamic role in the economic landscape of the region. Our mission? To support the development of local businesses as an active, long-term minority investor, in line with the needs and economic pace of businesses. Our commitment is demonstrated through four investment funds: - SOFILARO provides equity support to mature businesses in their development and transfers - CALEN (Crédit Agricole Languedoc Energies Nouvelles) invests in renewable energy infrastructure contributing to the region's energy transition - SOFILARO DETTE PRIVEE … Type: | 24 | 7 | 17 | 12 |
 | Airfinity Ltd The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary … Type: | 18 | 0 | 18 | 98 |
 | Akili Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and … Type: | 11 | 2 | 8 | 133 |
 | Deep Knowledge Analytics The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group. DeepTech industry analytics, benchmarking and forecasting renowned for its analytics and strategic consulting services on AI and DeepTech. Its Pharma Division is the leading provider of deep industry intelligence for the AI in Pharma sector. AI, artificial intelligence, big data, DeepTech, FinTech, data science, machine learning, GovTech, InvestTech, Blockchain, drug discovery, pharma, longevity, aging, healthspan, geroscience, agetech, preventive medicine, big data analysis, and data Type: | 13 | 0 | 11 | 9 |
 | Pharmaceutiques [Automatic translation follows] The reference information of the pharmaceutical sector Since 1992, the economic, political and regulatory news of the players of the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Reports of major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files Type: | 61 | 13 | 56 | 56 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 41 | 12 | 37 | 39 |
 |  World Health Organization We are the United Nations’ health agency. We are committed to achieve better health for everyone, everywhere. The World Health Organization's mission: to promote health, keep the world safe, and serve the vulnerable. Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people. Stay connected with WHO: Facebook https://www.facebook.com/WHO Twitter http://www.twitter.com/who Instagram: @who Google+ https://www.google.com/+who YouTube http://www.youtube.com/who Global Health, Health Trends, Health Research, Health Statistics, Disease Prevention, and Health Promotion Type: | 185 | 115 | 29 | 46 |
 | Maze Therapeutics At Maze, we envision a world where genetic insights inspire new medicines. Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders. Type: | 1 | 0 | 1 | 127 |
 | Tetra Therapeutics Restoring Clarity of Thought Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia. The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information. Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program. Our PDE4B platform addresses neuroinflammation, progressive multiple sclerosis (MS), and chronic traumatic encephalopathy (CTE). drug discovery, Alzheimer's Disease, schizophrenia, PDE4D, PDE4B, Fragile X, … Type: | 1 | 1 | 0 | 7 |
 | Qpex Biopharma Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an … Type: | 1 | 1 | 1 | 24 |
 | Apnimed Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders. Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders. sleep medicine and Obstructive Sleep Apnea | 1 | 1 | 0 | 70 |
 |  Partnership to Fight Infectious Disease Collaborating in the Fight for Health The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, business and labor groups, and health policy experts working to advance awareness and action on antimicrobial resistance. As an initiative of the Partnership to Fight Chronic Disease, PFID is focusing on the impact of this growing issue on our population and health care system. In particular, we will explore and advance solutions to address the threat of antimicrobial resistance and the need for new antimicrobial treatments. Type: | 1 | 1 | 0 | 2 |
 | Orchid Pharma Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 50 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, Our pharmaceutical solutions include active pharmaceutical ingredients (API), We are globally present across 40+ countries through alliances and partnerships with globally reputed majors. Our integrated business model enables us to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic … Type: | 1 | 1 | 0 | 1,716 |
 | Biomedical Advanced Research and Development Authority (BARDA) Advancing countermeasures against 21st century health threats. Part of HHS/ASPR. https://medicalcountermeasures.gov The Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA enhances the nation's public health security and emergency preparedness by facilitating communication on innovative products and solutions between federal agencies and public stakeholders. Type: | 4 | 1 | 3 | 101 |
 | CARB-X Non-profit global partnership funding the development of products that target the most serious drug-resistant bacteria CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germany’s Federal Ministry of Education … Type: | 3 | 1 | 2 | 34 |
 | FRAXA Research Foundation FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. FRAXA Research Foundation is a national 501c3 nonprofit organization. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. FRAXA also supports families affected by Fragile X syndrome and raises … Type: | 1 | 1 | 1 | 13 |
 | National Fragile X Foundation Our mission is to provide unwavering support for every family affected by Fragile X, while relentlessly pursuing a cure. The National Fragile X Foundation has been committed since the organization was formed in 1984 to help families, spread awareness, find improved treatments, and support research leading to better treatments and an eventual cure for all Fragile X-associated disorders. Mission The National Fragile X Foundation unites the Fragile X community to: - Enrich lives through educational and emotional support - Promote public and professional awareness - Advance research toward improved treatments and a cure for Fragile X. Advocacy, Support, Awareness, and … Type: | 1 | 1 | 1 | 35 |
 | Global Coalition on Aging We’re the world’s leading business voice on aging-related policy and strategy. The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth. Type: | 7 | 2 | 6 | 11 |
 | Ronald McDonald House Charities of South Florida Keeping Families Close since 1982. The Ronald McDonald House is located on the grounds of Jackson Memorial Hospital. The mission of Ronald McDonald House Charities® (RMHC®) is to support the health and well being of children by providing lodging, meals, activities and a community of care to critically ill children and their families who need to be near a hospital for treatment. Human Services, Family, Children, Hospital services, Hospitality, Housing, Pediatric, Volunteers, Non profit, and Philanthropy Type: | 1 | 1 | 0 | 15 |
 | Impact 4 Good Connecting Corporations & Communities though CSR teambuilding events! Since 2005, Impact 4 Good has been an innovator in the CSR team building industry, focused on national and international delivery of community-service based activities. Dedicated to providing programs that create significant bonding experiences across corporate teams while providing beneficial services and goods to those in need, we provide a unique value add to everyone involved. Exciting and engaging team building activities are just part of what we offer. Let us identify the best cause/beneficiary to support, manage the donation logistics and bring the spirit of community service to your group. From … | 1 | 1 | 0 | 25 |
 | Novus GmbH BE AHEAD NOVUS is not just an electric motorbike. NOVUS is not just a brand. NOVUS is the conviction that it can create things that do not yet exist. NOVUS stands for continuing where others say it doesn't work. NOVUS thinks ahead. We have created something between a bicycle and a motorbike. Our NOVUS One weighs only 104 kg, but with 25 kW peak power and 400 nm torque it is a benchmark in the 125cc class. A NOVUS conveys a very special feeling that no other two-wheeler can. The feeling of riding the future. That's what we've done all … Type: | 49 | 32 | 19 | 5 |
 | Infectious Diseases Society of America Elevating the Field of Infectious Diseases The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. Type: | 9 | 4 | 4 | 149 |
 | CardiaTec Biosciences Decoding the biology behind cardiovascular disease CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics. Type: | 5 | 2 | 2 | 10 |
 | Greater Geneva Bern area (GGBa) We help international companies set up successful business operations in Western Switzerland. Greater Geneva Bern area (GGBa) is the official investment promotion agency for Western Switzerland. Its mission is to support foreign companies so that they can quickly establish and develop their operations in Western Switzerland. Its services include: providing information on business environment, taxation, operational costs and labor law; facilitating contacts with peer companies and industry groups; evaluating the best location for each company’s needs and finding suitable premises. This support is provided at no charge and on a confidential basis. Since its creation in 2010, GGBa has successfully … | 40 | 2 | 39 | 40 |
 | Global Antibiotic R&D Partnership (GARDP) Putting public health needs at the centre of antibiotic drug development to address the crisis of AMR The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, … Type: | 15 | 2 | 12 | 97 |
 | American Chamber of Commerce in Japan The Voice of Global Business in Japan Established in 1948 by representatives of 40 American firms, the ACCJ, a fully independent chamber of commerce, has grown into one of the most influential business organizations in Japan, with approximately 3,000 members representing over 40 countries and 600 companies. More than 60 Chamber committees, subcommittees, task forces, and advisory councils cover such diverse areas as financial services, corporate social responsibility, marketing, independent business, healthcare services, e-business, transportation and logistics, legal services, the travel industry, and human resource management. Each committee establishes goals at the beginning of the year and meets regularly to … Type: | 8 | 0 | 4 | 200 |
 | Biocom California Accelerating life science. Biocom California is the state’s most powerful life science advocate. We believe life science advances humanity and we support over 1,800 member companies who share this vision with unparalleled resources to reach their full potential. Biocom California accelerates member success by driving effective public policy, creating access to capital, unlocking savings through robust member-vetted purchasing solutions, and developing the workforce of the future. We move the industry forward by building stronger networks across the state and building bridges from California to the rest of the world. Biotech, MedicalDevice, Diagnostic, Pharmaceuticals, ServiceProvider, Marketing, Networking and PurchasingGroup., Advocacy, Membership, … Type: | 50 | 7 | 42 | 190 |
 | Clinton Health Access Initiative, Inc. A global health organization committed to saving lives, reducing the burden of disease and strengthening health systems. CHAI's mission is to save lives and improve health outcomes in low- and middle-income countries by enabling the government and private sector to strengthen and sustain quality health systems. Today, CHAI operates in 36 countries across the world and more than 80 countries have access to CHAI-negotiated price reductions, vaccines, medical devices, and diagnostics. Current programs at CHAI include HIV/AIDS, Malaria, Tuberculosis, Hepatitis, Maternal, Newborn and Reproductive Health, Diarrhea and Pneumonia, Nutrition, Vaccines, Health Financing, Health Workforce, and Cancer. CHAI also has a … Type: | 24 | 7 | 15 | 2,010 |
 | Medicines Patent Pool Increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with 13 patent holders for 13 HIV antiretrovirals, one HIV technology … Type: | 16 | 3 | 12 | 73 |
 | Universität Greifswald [Automatic translation follows] Knowledge attracts. Since 1456 Brief profile of the University of Greifswald The University of Greifswald is one of the oldest academic educational institutions in Germany and the Baltic region. Founded in 1456, it is also the oldest Swedish university, as the region was under Swedish rule after the end of the Thirty Years' War until 1815. Today it is a tradition-conscious and modern university on the Baltic Sea with diverse international relations and partnerships. With around 220 professorships and around 10,000 students, it is one of the medium-sized universities. The low staff-to-student ratio and the short distances … Type: | 4 | 1 | 0 | 929 |
 | Global Health Innovative Technology (GHIT) Fund The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, … Type: | 8 | 1 | 5 | 23 |
 | AMR Industry Alliance The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify … Type: | 12 | 2 | 6 | 11 |
Incubators & VCs